Találati lista | Tudóstér

001-es BibID:	BIBFORM004763
Első szerző:	Bágyi Kinga (fogszakorvos)
Cím:	Efficacy of pre-operative cephalosporin prophylaxis in controlling pathogenic oral bacterial growth in comatose patients / Bagyi Kinga, Márton Ildikó, Szabó Judit, Andrási Melinda, Gáspár Attila, Varga Imre, Bognár László, Klekner Álmos
Dátum:	2008
Megjegyzések:	Pre-operative cephalosporin prophylaxis is routinely administered to patients in many institutes. In the case of patients with long-term endotracheal intubation, saliva that accumulates in the pharynx can flow down into the lungs. In particular, this can occur following neurosurgical procedures in comatose patients when pharyngeal and coughing reflexes are impaired. Aspiration of pathogenic bacteria from the oral cavity can in turn lead to pneumonia. In this study, the efficacy of prophylactic cephalosporins in controlling the growth of oral bacteria was investigated. Methods: At the time of induction of anaesthesia for a neurosurgical procedure, 10, 11, and 9 comatose patients received 1 g of cefazolin, 1.5 g of cefuroxime, or 2 g cefamandole, respectively. Antibiotic concentrations were measured by capillary electrophoresis in the serum and saliva at the end of the procedure. Bacteria were isolated from the same saliva samples and the MIC values for the specific cephalosporin were determined. Results: The mean concentrations of the cephalosporins in the serum exceeded the MIC values for almost every bacterium tested. However, the antibiotic concentrations were much lower in the saliva and did not reach the MIC values of 75-76% of the bacteria isolated from the same source. Conclusions: Surgical prophylaxis with cefazolin, cefuroxime, and cefamandole did not result in effective concentrations in the saliva to control the growth of pathogenic oral flora. Determination of the MIC values for bacteria isolated from the saliva can help in selecting appropriate antibiotics for the prevention of aspiration pneumonia. The simple application of capillary electrophoresis to human biological samples offers the possibility of evaluating the actual effectiveness of antibiotics that can promote optimisation of individual antibiotic therapy.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban cephalosporins prophylaxisv aspiration pneumonia neurosurgery egyetemen (Magyarországon) készült közlemény
Megjelenés:	Journal of Medical Microbiology. - 57 : Pt1 (2008), p. 128-129. -
További szerzők:	Márton Ildikó (1954-) (fogszakorvos) Szabó Judit (1963-) (szakorvos, klinikai mikrobiológus) Andrási Melinda (1979-) (gyógyszerész) Gáspár Attila (1970-) (vegyész, kémikus) Varga Imre (1960-) (tüdőgyógyász) Bognár László (1958-) (idegsebész, gyermekidegsebész) Klekner Álmos (1970-) (idegsebész)
Internet cím:	elektronikus változat DOI
Borító:
Saját polcon:

001-es BibID:	BIBFORM066031
Első szerző:	Bozó Aliz (biológus)
Cím:	The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model / Aliz Bozó, Marianna Domán, László Majoros, Gábor Kardos, István Varga, Renátó Kovács
Dátum:	2016
ISSN:	1225-8873
Megjegyzések:	Farnesol is a quorum-sensing molecule that inhibits biofilm formation in Candida albicans. Previous in vitro data suggest that, in combination with certain antifungals, farnesol may have an adjuvant anti-biofilm agent. However, the in vivo efficacy of farnesol is very questionable. Therefore, the in vitro and in vivo activity of fluconazole combined with farnesol was evaluated against C. albicans biofilms using fractional inhibitory concentration index (FICI) determination, time-kill experiments and a murine vulvovaginitis model. The median biofilm MICs of fluconazole-sensitive C. albicans isolates ranged between 4 -> 512 mg/L and 150-300 ?M for fluconazole and farnesol, respectively. These values were 512 -> 512 mg/L and > 300 ?M for fluconazole-resistant clinical isolates. Farnesol decreased the median MICs of fluconazole by 2-64-fold for biofilms. Based on FICI, synergistic interaction was observed only in the case of the sessile SC5314 reference strain (FICIs: 0.16-0.27). In time-kill studies, only the 512 mg/L fluconazole and 512 mg/L fluconazole + 75 ?M farnesol reduced biofilm mass significantly at each time point in the case of all isolates. The combination reduced the metabolic activity of biofilms for all isolates in a concentration- and time-dependent manner. Our findings revealed that farnesol alone was not protective in a murine vulvovaginitis model. Farnesol was not beneficial in combination with fluconazole for fluconazole-susceptible isolates, but partially increased fluconazole activity against one fluconazole-resistant isolate, but not the other one.
Tárgyszavak:	Orvostudományok Gyógyszerészeti tudományok idegen nyelvű folyóiratközlemény külföldi lapban FIC index fluconazole-resistant murine vulvovaginitis synergy time-kill experiment
Megjelenés:	Journal Of Microbiology 54 : 11 (2016), p. 753-760. -
További szerzők:	Domán Marianna (1987-) (biológus) Majoros László (1966-) (szakorvos, klinikai mikrobiológus) Kardos Gábor (1974-) (szakorvos, klinikai mikrobiológus) Varga István (1974-) (fogszakorvos) Kovács Renátó László (1987-) (molekuláris biológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM018050
Első szerző:	Klekner Álmos (idegsebész)
Cím:	Effectiveness of Cephalosporins in the Sputum of Patients with Nosocomial Bronchopneumonia / Klekner A., Bagyi K., Bognar L., Gaspar A., Andrasi M., Szabo J.
Dátum:	2006
ISSN:	0095-1137
Megjegyzések:	Nosocomial bronchopneumonia is a frequent complication in patients with chronic intratracheal intubation. Despite targeted antibiotic treatment, production of abundant bronchial secretion containing pathogen bacteria often tends to be chronic, and so mortality drastically increases. This problem led to an investigation of the penetration of five cephalosporin antibiotics into the sputum. Serum and sputum were collected from 24 chronically intubated patients having purulent nosocomial bronchopneumonia treated in an intensive care unit (ICU). Patients received the following doses intravenously every 24 h: five received 70 mg/kg of body weight cefuroxime, four received 110 mg/kg cefamandole, six received 80 mg/kg ceftriaxone, four received 80 mg/kg ceftazidime, and five received 80 mg/kg cefepime. Antibiotic concentrations in the serum and sputum were evaluated by capillary electrophoresis. MICs were determined for bacteria isolated from the purulent bronchial secretions. The mean levels of the cephalosporins in the sputum did not reach the MICs for the bacteria isolated from the same samples. Ceftriaxone was the only one of the investigated five cephalosporins that had a measurable concentration in the sputum (1.4 ? 1.2 mg/liter). The low concentration of antibiotics in the purulent tracheobronchial secretion can be one of the many reasons for ineffective therapy of nosocomial bronchopneumonia in intubated patients in the ICUs. In the case of intubated or mechanically ventilated patients having chronic bronchopneumonia, determination of drug concentration in the bronchial secretion might be considered when selecting an antibiotic for treatment.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban egyetemen (Magyarországon) készült közlemény
Megjelenés:	Journal Of Clinical Microbiology. - 44 : 9 (2006), p. 3418-3421. -
További szerzők:	Bágyi Kinga (1971-) (fogszakorvos) Bognár László (1958-) (idegsebész, gyermekidegsebész) Gáspár Attila (1970-) (vegyész, kémikus) Andrási Melinda (1979-) (gyógyszerész) Szabó Judit (1963-) (szakorvos, klinikai mikrobiológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: